SAN DIEGO--(BUSINESS WIRE)--Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating if securities violations were committed by Medbox, Inc. (OTC Markets: MDBX) by communicating erroneous information about the Company’s operations and financial results.

On February 18, 2014, Citron Research issued a report stating that Medbox “has systematically and repeatedly committed FRAUD on their financial statements, and the public statements they make about their financials are laced with lies.” Per the research report, Medbox has deceived the public many times and also purported this practice during a period they raised capital.

On this reported news, Medbox’s stock dropped over 17% in mid day trading today, February 18, 2014. Though Citron’s evidence indicates multiple securities violations, this investigation will focus on Medbox’s financial reporting and the potential deception presented to shareholders and the public.

If you are a Medbox shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (jimb@johnsonandweaver.com) at 619-230-0063.

Johnson & Weaver, LLP is a nationally recognized shareholders’ rights law firm. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.